• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$44.05 $1.38 (3.23%)

REAL-TIME: Last trade at

United Therapeutics Corp

NASDAQ:UTHR

Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeut

Neutral on United Therapeutics - Analyst Blog

UTHR Files Suit vs. Sandoz - Analyst Blog

Action Date for UTHR Candidate - Analyst Blog

UTHR Misses Expectations - Analyst Blog

United Therapeutics Earnings Preview

Generic Challenge for UTHR's Remodulin - Analyst Blog

United Therapeutics Passes This Key Test

EU Nod for UTHR's Remodulin IV - Analyst Blog

United Therapeutics Corp - Aggressive Growth

Zacks Releases Four Powerful ''Buy'' Stocks: United Therapeutics, Monsanto, Universal and Genesco -

United Therapeutics Enters Oversold Territory - Tale of the Tape

The Stocks Wall Street Loves

United Therapeutics to Offer $210M in Debt

1 Reason the Street Should Love Gilead Sciences' Earnings

Is United Therapeutics Earning Its Keep?

This Just In: More Upgrades and Downgrades

Why Did My Stock Just Die?

United Therapeutics Shares Got Crushed: What You Need to Know

United Therapeutics Plunges on Missed Study Goal

United Therapeutics' CEO Discusses Q2 2011 Results - Earnings Call Transcript

6 High-Growth Stocks With Improving Operating Cash Flow

Analyst Calls: AET, AKAM, BBY, DVN, HOG, IMAX, LVS, RIMM, UNH, URBN ...

United Therapeutics for Profits and Pipeline

Russell 1,000 Stocks With the Lowest PEG Ratios

13 Mid-Cap Stocks Headed for Bellwether Status Soon

Analyst Calls: AEP, AKS, AMAT, EZCH, FRX, LOPE, MYGN, PNW, ZION ...

Shopping for Growth Stocks at Value Prices

5 Growth Stocks at Reasonable Valuations

Do Mergers Mean Billions for Biotech?

Do Mergers Means Billions for Biotech?

Healthcare Sector: Stronger Than It Looks

Wednesday Options Brief: SLXP, UTHR, XLB & XLE

Life Science Portfolios: Reflecting on a Year of Out-Performance

20 Breakout Stocks Being Targeted by Short Sellers

Earnings Could Drive These Two Stocks Higher

Cypress Bioscience Calls and NetSuite Puts Heating Up

China Biotech in Review: Pharma IPOs Raise $5.4 Billion in 12 Months

Analyst Calls: ANDS, AZO, CHRW, CR, CRM, FDO, GIS, K, NAV, ORCL ...

UPDATE 1-United Therapeutics Q1 results beat expectations

See More Articles...